These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10709304)

  • 1. The costs of treating rheumatoid arthritis patients with complementary medicine: exploring the issue.
    van Haselen RA; Graves N; Dahiha S
    Complement Ther Med; 1999 Dec; 7(4):217-21. PubMed ID: 10709304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic evaluation of complementary medicine: a staged approach at the Royal London Homeopathic Hospital.
    van Haselen R
    Br Homeopath J; 2000 Jul; 89 Suppl 1():S23-6. PubMed ID: 10939778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice.
    Buchbinder R; Gingold M; Hall S; Cohen M
    Intern Med J; 2002; 32(5-6):208-14. PubMed ID: 12036218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome.
    Callaghan R; Prabu A; Allan RB; Clarke AE; Sutcliffe N; Pierre YS; Gordon C; Bowman SJ;
    Rheumatology (Oxford); 2007 Jan; 46(1):105-11. PubMed ID: 16728437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
    Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
    Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
    Hallert E; Husberg M; Jonsson D; Skogh T
    Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
    Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
    Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of complementary therapies by patients attending musculoskeletal clinics.
    Chandola A; Young Y; McAlister J; Axford JS
    J R Soc Med; 1999 Jan; 92(1):13-6. PubMed ID: 10319029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation.
    Lambert CM; Hurst NP; Forbes JF; Lochhead A; Macleod M; Nuki G
    BMJ; 1998 Mar; 316(7136):965-9. PubMed ID: 9550954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditing outcomes and costs of integrated complementary medicine provision--the importance of length of follow up.
    Robinson N; Donaldson J; Watt H
    Complement Ther Clin Pract; 2006 Nov; 12(4):249-57. PubMed ID: 17030296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Pharmacoeconomics; 2005; 23(4):377-93. PubMed ID: 15853437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care centre.
    Zaman T; Agarwal S; Handa R
    Natl Med J India; 2007; 20(5):236-9. PubMed ID: 18254519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary medicine use and costs in patients with breast cancer who experienced treatment-related side effects: A cross-sectional survey in Korea.
    Han S; Jang BH; Suh HS; Hwang DS
    Complement Ther Med; 2019 Jun; 44():210-217. PubMed ID: 31126558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare resource utilization and costs among patients with rheumatoid arthritis on biologic therapies in Taiwan: A 1-year mirror-image study using a national claims database.
    Chen KC; Wu CH; Tang CH; Huang KC
    PLoS One; 2018; 13(7):e0200758. PubMed ID: 30020997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared care or nurse consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis (RA) outpatients with stable low disease-activity RA: cost-effectiveness based on a 2-year randomized trial.
    Sørensen J; Primdahl J; Horn HC; Hørslev-Petersen K
    Scand J Rheumatol; 2015; 44(1):13-21. PubMed ID: 25380077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
    Hu H; Luan L; Yang K; Li SC
    Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.
    Brennan A; Bansback N; Nixon R; Madan J; Harrison M; Watson K; Symmons D
    Rheumatology (Oxford); 2007 Aug; 46(8):1345-54. PubMed ID: 17562686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding Rheumatoid Arthritis Impact on Life (FRAIL Study): economic burden.
    Miranda LC; Santos H; Ferreira J; Coelho P; Silva C; Saraiva-Ribeiro J;
    Acta Reumatol Port; 2012; 37(2):134-42. PubMed ID: 23149635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital costs of treating haemophilic patients infected with HIV.
    Kennelly JM; Tolley KH; Ghani AC; Sabin CA; Maynard AK; Lee CA
    AIDS; 1995 Jul; 9(7):787-93. PubMed ID: 7546425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
    Zhu TY; Tam LS; Li EK
    Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.